TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.650
+0.185 (4.14%)
At close: Mar 9, 2026, 4:00 PM EDT
4.615
-0.035 (-0.75%)
After-hours: Mar 9, 2026, 4:10 PM EDT
TriSalus Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 20.44 | 8.53 | 11.78 | 9.41 | 30.3 | Upgrade
|
| Cash & Short-Term Investments | 20.44 | 8.53 | 11.78 | 9.41 | 30.3 | Upgrade
|
| Cash Growth | 139.75% | -27.61% | 25.10% | -68.93% | 575.16% | Upgrade
|
| Receivables | 6.56 | 5.09 | 3.55 | 1.56 | 1.36 | Upgrade
|
| Inventory | 3.08 | 4.05 | 2.55 | 1.47 | 1.29 | Upgrade
|
| Prepaid Expenses | 2.17 | 3.01 | 2.99 | 4.77 | 2.18 | Upgrade
|
| Total Current Assets | 32.24 | 20.67 | 20.86 | 17.21 | 35.13 | Upgrade
|
| Property, Plant & Equipment | 2.67 | 2.88 | 3.27 | 3.61 | 1.8 | Upgrade
|
| Other Intangible Assets | - | - | - | 0.8 | 0.79 | Upgrade
|
| Other Long-Term Assets | 0.42 | 0.42 | 0.47 | 0.37 | 0.12 | Upgrade
|
| Total Assets | 35.33 | 23.97 | 24.6 | 22 | 37.84 | Upgrade
|
| Accounts Payable | 3 | 2.27 | 3.39 | 4.95 | 1.3 | Upgrade
|
| Accrued Expenses | 8 | 7.32 | 10.53 | 6.38 | 4.97 | Upgrade
|
| Current Portion of Leases | 0.17 | 0.22 | 0.35 | 0.37 | - | Upgrade
|
| Current Income Taxes Payable | 0.1 | 0.03 | 0.03 | - | - | Upgrade
|
| Other Current Liabilities | 0.23 | 0.38 | 0.39 | 20.66 | 0.1 | Upgrade
|
| Total Current Liabilities | 11.5 | 10.23 | 14.69 | 32.36 | 6.37 | Upgrade
|
| Long-Term Debt | 33.05 | 22.08 | - | - | - | Upgrade
|
| Long-Term Leases | 1.23 | 1.33 | 1.24 | 1.59 | - | Upgrade
|
| Other Long-Term Liabilities | 23.42 | 16.22 | 35.73 | 0.37 | 0.56 | Upgrade
|
| Total Liabilities | 69.19 | 49.87 | 51.66 | 34.32 | 6.93 | Upgrade
|
| Common Stock | 0 | 0 | 0 | - | 0.01 | Upgrade
|
| Additional Paid-In Capital | 296.72 | 253.65 | 222.44 | 10.03 | 6.73 | Upgrade
|
| Retained Earnings | -330.58 | -279.55 | -249.5 | -186.36 | -136.34 | Upgrade
|
| Total Common Equity | -33.86 | -25.89 | -27.07 | -176.33 | -129.6 | Upgrade
|
| Shareholders' Equity | -33.86 | -25.89 | -27.07 | -12.32 | 30.9 | Upgrade
|
| Total Liabilities & Equity | 35.33 | 23.97 | 24.6 | 22 | 37.84 | Upgrade
|
| Total Debt | 34.44 | 23.63 | 1.6 | 1.96 | - | Upgrade
|
| Net Cash (Debt) | -14 | -15.1 | 10.18 | 7.45 | 30.3 | Upgrade
|
| Net Cash Growth | - | - | 36.65% | -75.41% | - | Upgrade
|
| Net Cash Per Share | -0.37 | -0.60 | 1.08 | 24.07 | 3.42 | Upgrade
|
| Filing Date Shares Outstanding | 61.31 | 32.27 | 26.76 | 14.08 | 12.96 | Upgrade
|
| Total Common Shares Outstanding | 50 | 31.28 | 26.41 | 14.08 | 10.72 | Upgrade
|
| Working Capital | 20.75 | 10.44 | 6.18 | -15.14 | 28.76 | Upgrade
|
| Book Value Per Share | -0.68 | -0.83 | -1.02 | -12.53 | -12.09 | Upgrade
|
| Tangible Book Value | -33.86 | -25.89 | -27.07 | -177.13 | -130.4 | Upgrade
|
| Tangible Book Value Per Share | -0.68 | -0.83 | -1.02 | -12.58 | -12.16 | Upgrade
|
| Machinery | 3.21 | 4.34 | 3.8 | 3.87 | 3.15 | Upgrade
|
| Construction In Progress | 0.25 | 0.33 | 0.6 | - | - | Upgrade
|
| Leasehold Improvements | 1.57 | 0.77 | 0.77 | 0.77 | 0.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.